Here we present the Frontiers in Pharmacology ‘Emerging Talents in’ article collection. A series dedicated to highlighting the emerging talent of student researchers within the field of Pharmacology of Anti-Cancer Drugs.
Across the world students are undertaking key research as part of their education in Pharmacology of Anti-Cancer Drugs, however, most of this research is not communicated to the wider audience. We recognize that this is because many student researchers find the thought of peer-review daunting. At Frontiers, peer-review is considered a collaborative process and our interactive peer-review is tailored to provide hands-on guidance and constructive feedback to researchers. Our Topic Editors are committed to the development of emerging talents and want to see student researchers strive for success at publications.
The research presented here highlights the quality and diversity of student researchers across the field of Pharmacology of Anti-Cancer Drugs. We welcome contributions in the form of original research, review, mini review, case report, hypothesis and theory, perspective, both experimental and computational studies that cover, but are not limited to, following themes:
1. Remodeling Cancer Epigenome: Therapeutic Advances
2. Cancer Immunosurveillance: From Mechanisms to Therapy
3. Anticancer Drug Discovery and Translational Oncology
This Research Topic will help to identify emerging leaders and allow the community to follow the aspiring careers of our emerging, talented researchers. #EmergingTalentsIn
Please note: To be considered for this collection, the first and/or collaborating first, or second author will be a registered undergraduate or graduate student at time of submission.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in the mission statement. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Here we present the Frontiers in Pharmacology ‘Emerging Talents in’ article collection. A series dedicated to highlighting the emerging talent of student researchers within the field of Pharmacology of Anti-Cancer Drugs.
Across the world students are undertaking key research as part of their education in Pharmacology of Anti-Cancer Drugs, however, most of this research is not communicated to the wider audience. We recognize that this is because many student researchers find the thought of peer-review daunting. At Frontiers, peer-review is considered a collaborative process and our interactive peer-review is tailored to provide hands-on guidance and constructive feedback to researchers. Our Topic Editors are committed to the development of emerging talents and want to see student researchers strive for success at publications.
The research presented here highlights the quality and diversity of student researchers across the field of Pharmacology of Anti-Cancer Drugs. We welcome contributions in the form of original research, review, mini review, case report, hypothesis and theory, perspective, both experimental and computational studies that cover, but are not limited to, following themes:
1. Remodeling Cancer Epigenome: Therapeutic Advances
2. Cancer Immunosurveillance: From Mechanisms to Therapy
3. Anticancer Drug Discovery and Translational Oncology
This Research Topic will help to identify emerging leaders and allow the community to follow the aspiring careers of our emerging, talented researchers. #EmergingTalentsIn
Please note: To be considered for this collection, the first and/or collaborating first, or second author will be a registered undergraduate or graduate student at time of submission.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in the mission statement. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
